Condition
Immune System Disease
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Recruiting2
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07075185Phase 1Recruiting
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
NCT06169150Recruiting
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
NCT05650502Completed
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin
NCT02594878Phase 2UnknownPrimary
Chronic Non-bacterial Osteomyelitis Treated With Pamidronate
Showing all 4 trials